Works matching IS 03407004 AND DT 2013 AND VI 62 AND IP 4

Results: 18

Properties of monocytes generated from haematopoietic CD34 stem cells from bone marrow of colon cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 705, doi. 10.1007/s00262-012-1375-5

By:

Stec, Malgorzata;
Baran, Jarosław;
Szatanek, Rafał;
Mytar, Bożenna;
Lenart, Marzena;
Czupryna, Antoni;
Szczepanik, Antoni;
Siedlar, Maciej;
Zembala, Marek

Publication type:

Article

Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 677, doi. 10.1007/s00262-012-1368-4

By:

Sugie, Tomoharu;
Murata-Hirai, Kaoru;
Iwasaki, Masashi;
Morita, Craig;
Li, Wen;
Okamura, Haruki;
Minato, Nagahiro;
Toi, Masakazu;
Tanaka, Yoshimasa

Publication type:

Article

Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 639, doi. 10.1007/s00262-012-1366-6

By:

Nobuoka, Daisuke;
Yoshikawa, Toshiaki;
Takahashi, Mari;
Iwama, Tatsuaki;
Horie, Kazutaka;
Shimomura, Manami;
Suzuki, Shiro;
Sakemura, Noriko;
Nakatsugawa, Munehide;
Sadamori, Hiroshi;
Yagi, Takahito;
Fujiwara, Toshiyoshi;
Nakatsura, Tetsuya

Publication type:

Article

BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 787, doi. 10.1007/s00262-012-1382-6

By:

Cho, Hyun-Il;
Barrios, Kelly;
Lee, Young-Ran;
Linowski, Angelika;
Celis, Esteban

Publication type:

Article

Acknowledgement.

Published in:: Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 823, doi. 10.1007/s00262-013-1409-7
Publication type:: Article

Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 773, doi. 10.1007/s00262-012-1384-4

By:

McCormack, Emmet;
Adams, Katherine;
Hassan, Namir;
Kotian, Akhil;
Lissin, Nikolai;
Sami, Malkit;
Mujić, Maja;
Osdal, Tereza;
Gjertsen, Bjørn;
Baker, Deborah;
Powlesland, Alex;
Aleksic, Milos;
Vuidepot, Annelise;
Morteau, Olivier;
Sutton, Deborah;
June, Carl;
Kalos, Michael;
Ashfield, Rebecca;
Jakobsen, Bent

Publication type:

Article

Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 727, doi. 10.1007/s00262-012-1378-2

By:

Yang, Shicheng;
Ji, Yun;
Gattinoni, Luca;
Zhang, Ling;
Yu, Zhiya;
Restifo, Nicholas;
Rosenberg, Steven;
Morgan, Richard

Publication type:

Article

CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 747, doi. 10.1007/s00262-012-1381-7

By:

Corgnac, Stéphanie;
Perret, Rachel;
Derré, Laurent;
Zhang, Lianjun;
Stirnemann, Kathrin;
Zauderer, Maurice;
Speiser, Daniel;
Mach, Jean-Pierre;
Romero, Pedro;
Donda, Alena

Publication type:

Article

Impaired immunomodulatory function of chronic myeloid leukemia cancer stem cells and the possible mechanism involved in it.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 689, doi. 10.1007/s00262-012-1367-5

By:

Xishan, Zhu;
Xinna, Zhou;
baoxin, He;
Jun, Ren

Publication type:

Article

TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4CD25 Treg apoptosis.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 653, doi. 10.1007/s00262-012-1370-x

By:

Diao, Zhijuan;
Shi, Juan;
Zhu, Jieqing;
Yuan, Haiqin;
Ru, Qiang;
Liu, Shilian;
Liu, Yanxin;
Zheng, Dexian

Publication type:

Article

Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 737, doi. 10.1007/s00262-012-1380-8

By:

Cabrera, Roniel;
Ararat, Miguel;
Xu, Yiling;
Brusko, Todd;
Wasserfall, Clive;
Atkinson, Mark;
Chang, Lung;
Liu, Chen;
Nelson, David

Publication type:

Article

Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 615, doi. 10.1007/s00262-012-1359-5

By:

Filbert, Helene;
Attig, Sebastian;
Bidmon, Nicole;
Renard, Bernhard;
Janetzki, Sylvia;
Sahin, Ugur;
Welters, Marij;
Ottensmeier, Christian;
Burg, Sjoerd;
Gouttefangeas, Cécile;
Britten, Cedrik

Publication type:

Article

Enhancement of the anti-melanoma response of Hu14.18K322A by αCD40 + CpG.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 665, doi. 10.1007/s00262-012-1372-8

By:

Alderson, Kory;
Luangrath, Mitchell;
Elsenheimer, Megan;
Gillies, Stephen;
Navid, Fariba;
Rakhmilevich, Alexander;
Sondel, Paul

Publication type:

Article

The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 761, doi. 10.1007/s00262-012-1377-3

By:

Durán-Aniotz, Claudia;
Segal, Gabriela;
Salazar, Lorena;
Pereda, Cristián;
Falcón, Cristián;
Tempio, Fabián;
Aguilera, Raquel;
González, Rodrigo;
Pérez, Claudio;
Tittarelli, Andrés;
Catalán, Diego;
Nervi, Bruno;
Larrondo, Milton;
Salazar-Onfray, Flavio;
López, Mercedes

Publication type:

Article

Functional human Th17 clones with WT1-specific helper activity.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 801, doi. 10.1007/s00262-012-1385-3

By:

Tachino, Sho;
Fujiki, Fumihiro;
Oka, Yoshihiro;
Tsuboi, Akihiro;
Morimoto, Soyoko;
Lin, Yu-Hung;
Tamanaka, Taichi;
Kondo, Kenta;
Nakajima, Hiroko;
Nishida, Sumiyuki;
Hosen, Naoki;
Oji, Yusuke;
Kumanogoh, Atsushi;
Sugiyama, Haruo

Publication type:

Article

Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 715, doi. 10.1007/s00262-012-1373-7

By:

Held, Stefanie;
Duchardt, Katharina;
Tenzer, Stefan;
Rückrich, Thomas;
Schwarzenberg, Karin;
Bringmann, Anita;
Kurts, Christian;
Schild, Hansjörg;
Driessen, Christoph;
Brossart, Peter;
Heine, Annkristin

Publication type:

Article

Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 629, doi. 10.1007/s00262-012-1371-9

By:

Baghdadi, Muhammad;
Nagao, Hiroko;
Yoshiyama, Hironori;
Akiba, Hisaya;
Yagita, Hideo;
Dosaka-Akita, Hirotoshi;
Jinushi, Masahisa

Publication type:

Article

Inhibition of both BRAF and MEK in BRAF mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 811, doi. 10.1007/s00262-012-1389-z

By:

Ott, Patrick;
Henry, Trevor;
Baranda, Sonja;
Frleta, Davor;
Manches, Olivier;
Bogunovic, Dusan;
Bhardwaj, Nina

Publication type:

Article